Lorraine A. Chantrill

12.6k total citations
48 papers, 885 citations indexed

About

Lorraine A. Chantrill is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lorraine A. Chantrill has authored 48 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Lorraine A. Chantrill's work include Pancreatic and Hepatic Oncology Research (20 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (9 papers). Lorraine A. Chantrill is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Cancer Genomics and Diagnostics (12 papers) and Colorectal Cancer Treatments and Studies (9 papers). Lorraine A. Chantrill collaborates with scholars based in Australia, United Kingdom and United States. Lorraine A. Chantrill's co-authors include Ilse Rooman, Andreia V. Pinho, Andrew V. Biankin, Adnan Nagrial, Venessa Chin, Anthony J. Gill, Jaswinder S. Samra, David K. Chang, Amber L. Johns and Marina Pajic and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lorraine A. Chantrill

44 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorraine A. Chantrill Australia 14 605 246 206 185 170 48 885
Venessa Chin Australia 14 591 1.0× 222 0.9× 222 1.1× 299 1.6× 167 1.0× 46 916
Feng Luo China 16 477 0.8× 133 0.5× 157 0.8× 276 1.5× 168 1.0× 61 943
Jonathan M. Harnoss Germany 16 562 0.9× 347 1.4× 270 1.3× 519 2.8× 127 0.7× 34 1.3k
Yunpeng Peng China 20 574 0.9× 248 1.0× 244 1.2× 430 2.3× 168 1.0× 49 1.2k
Fuminori Sonohara Japan 17 448 0.7× 301 1.2× 264 1.3× 378 2.0× 227 1.3× 64 960
Joo Han Lim South Korea 18 393 0.6× 94 0.4× 163 0.8× 335 1.8× 144 0.8× 61 867
Takaaki Mizushima Japan 15 288 0.5× 298 1.2× 111 0.5× 328 1.8× 114 0.7× 34 886
Tomohito Tanaka Japan 18 291 0.5× 117 0.5× 208 1.0× 348 1.9× 93 0.5× 81 1.0k
Selliah Kanthan Canada 17 343 0.6× 352 1.4× 182 0.9× 264 1.4× 206 1.2× 32 1.1k

Countries citing papers authored by Lorraine A. Chantrill

Since Specialization
Citations

This map shows the geographic impact of Lorraine A. Chantrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine A. Chantrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine A. Chantrill more than expected).

Fields of papers citing papers by Lorraine A. Chantrill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine A. Chantrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine A. Chantrill. The network helps show where Lorraine A. Chantrill may publish in the future.

Co-authorship network of co-authors of Lorraine A. Chantrill

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine A. Chantrill. A scholar is included among the top collaborators of Lorraine A. Chantrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine A. Chantrill. Lorraine A. Chantrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Hansen, Thomas Fritz, et al.. (2024). Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer. SHILAP Revista de lepidopterología. 5(6). 1247–1260.
4.
Chantrill, Lorraine A., Hung‐Chih Hsu, Brigette Ma, et al.. (2024). Expert consensus on the optimal management of BRAFV600E‐mutant metastatic colorectal cancer in the Asia‐Pacific region. Asia-Pacific Journal of Clinical Oncology. 21(1). 31–45. 2 indexed citations
5.
6.
Hosseinzadeh, Hassan, et al.. (2023). Does Geography Play a Role in the Receipt of End-of-Life Care for Advanced Cancer Patients? Evidence from an Australian Local Health District Population-Based Study. Journal of Palliative Medicine. 26(11). 1453–1465. 2 indexed citations
7.
Woodford, Rachel, Daniel Brungs, Peter Grimison, et al.. (2021). Combination chemotherapy with NAB®‐paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP‐CAPABIL Pilot Study). Asia-Pacific Journal of Clinical Oncology. 18(5). e220–e226. 8 indexed citations
8.
9.
Goel, Shom, Jia Liu, Hao Guo, et al.. (2019). Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity. JACC Heart Failure. 7(9). 795–804. 30 indexed citations
10.
Pinho, Andreia V., Lorraine A. Chantrill, David Herrmann, et al.. (2018). ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. Nature Communications. 9(1). 5083–5083. 40 indexed citations
11.
Shapiro, Jeremy, Subotheni Thavaneswaran, Craig Underhill, et al.. (2018). Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. Clinical Colorectal Cancer. 17(4). 313–319. 8 indexed citations
12.
Qian, Jiahui, Anita Heywood, Surendra Karki, et al.. (2018). Risk of Herpes Zoster Prior to and Following Cancer Diagnosis and Treatment: A Population-Based Prospective Cohort Study. The Journal of Infectious Diseases. 220(1). 3–11. 28 indexed citations
13.
Chantrill, Lorraine A., Skye H. Simpson, Amber L. Johns, et al.. (2015). Abstract CT210: Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial. Cancer Research. 75(15_Supplement). CT210–CT210. 1 indexed citations
14.
Giry-Laterrière, Marc, Andreia V. Pinho, Nils Eling, Lorraine A. Chantrill, & Ilse Rooman. (2015). Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas. Current Cancer Drug Targets. 15(6). 463–468. 5 indexed citations
15.
Nagrial, Adnan, Venessa Chin, Katrin Marie Sjoquist, et al.. (2015). Role of chemoradiation in locally advanced pancreatic cancer: A systematic review and meta-analysis.. Journal of Clinical Oncology. 33(3_suppl). 348–348. 1 indexed citations
16.
Goel, Shom, Hao Guo, William T. Barry, et al.. (2015). Abstract P4-15-02: Clinical, biochemical, and genomic predictors of trastuzumab-related cardiotoxicity: Results of CATS. Cancer Research. 75(9_Supplement). P4–15. 1 indexed citations
17.
Tran, Thao, Stephen Della‐Fiorentina, David Adams, et al.. (2013). Survival times of women with metastatic breast cancer starting first‐line chemotherapy in routine clinical practice versus contemporary randomised trials. Internal Medicine Journal. 43(8). 883–888. 10 indexed citations
18.
Nagrial, Adnan, et al.. (2013). Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancer. Cochrane Database of Systematic Reviews. 1 indexed citations
19.
Murphy, Felicity, Diana Zannino, Kate Wilson, et al.. (2011). Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. Annals of Oncology. 22(8). 1834–1838. 38 indexed citations
20.
Jones, A. R., et al.. (1992). Metabolism of glycerol by mature boar spermatozoa. Reproduction. 94(1). 129–134. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Venessa Chin Breakdown of academic impact, for papers by Feng Luo Breakdown of academic impact, for papers by Jonathan M. Harnoss Breakdown of academic impact, for papers by Yunpeng Peng Breakdown of academic impact, for papers by Fuminori Sonohara Breakdown of academic impact, for papers by Joo Han Lim Breakdown of academic impact, for papers by Takaaki Mizushima Breakdown of academic impact, for papers by Tomohito Tanaka Breakdown of academic impact, for papers by Selliah Kanthan
Rankless by CCL
2026